![Rajesh K. Malik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rajesh K. Malik
Director/Board Member at
Meryx, Inc.
Profile
Rajesh K.
Malik's career history includes current and former positions as well as education.
Currently, Dr. Malik is the Director at Meryx, Inc. In the past, Dr. Malik held positions such as Associate Director at Bristol Myers Squibb Co. from 2000 to 2002, Executive Director at EMD Pharmaceuticals, Inc. from 2002 to 2004, Director & Chief Medical Officer at Agennix AG from 2007 to 2013, Independent Director at POINT Biopharma Global, Inc. from 2021 to 2023, and Chief Medical Officer at Fennec Pharmaceuticals, Inc. from 2004 to 2007.
Dr. Malik also served as an Assistant Professor at the University of Virginia and Chief Medical Officer at Agennix, Inc. Furthermore, Dr. Malik obtained a doctorate degree from the University of Sheffield Medical School.
Rajesh K. Malik active positions
| Companies | Position | Start |
|---|---|---|
Meryx, Inc.
 Meryx, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Director/Board Member | 2018-04-30 |
Former positions of Rajesh K. Malik
| Companies | Position | End |
|---|---|---|
| G1 THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-09-17 |
| POIT BIOP | Director/Board Member | 2023-12-26 |
| AGENNIX AG | Chief Tech/Sci/R&D Officer | 2012-12-31 |
| FENNEC PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 2006-12-31 |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Director/Board Member | 2003-12-31 |
Training of Rajesh K. Malik
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agennix, Inc.
 Agennix, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and for wound healing | Health Technology |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Agennix AG
 Agennix AG BiotechnologyHealth Technology Discovers, develops and commercializes new anti-cancer drugs | Health Technology |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
University of Sheffield Medical School
 University of Sheffield Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Rajesh K. Malik
